Sam Williams

Sam Williams is the Investor Director at Microbiotica Limited and has extensive experience in the biotechnology sector, spanning over 20 years. He has a diverse background that includes roles as a top-ranked equity analyst and as an entrepreneur. Currently, he also serves as the Executive Chairman of Istesso Limited and holds positions as a Non-Executive Director for Diurnal Group plc and Managing Partner for Life Sciences at IP Group.

Education and Background

• PhD in Molecular Biology from the University of Cambridge.
• Degree in Biology from the University of Oxford.

Professional Experience

• Microbiotica Limited: Investor Director, contributing to strategic oversight and investment decisions.
• Istesso Limited: Founding CEO, now serving as Chairman, focusing on drug discovery and development.
• IP Group: Managing Partner, Life Sciences, where he oversees various investments in biotech companies.

Other Roles

Sam Williams also serves on the boards of several other companies, including Pulmocide Ltd and Psioxus Ltd, showcasing his active involvement in advancing biopharmaceutical innovations.123